Today: 19 May 2026
Browse Category

NASDAQ:COHR 8 January 2026 - 9 February 2026

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp stock jumps 7% after BofA lifts target to $250 as AI data-center spending stays in focus

Coherent Corp shares jumped 7.2% to $244.13 Monday after Bank of America raised its price target to $250, maintaining a Neutral rating. The move followed volatile trading after earnings and comes as investors focus on AI-driven optical demand and upcoming U.S. inflation data. Other optical stocks also gained. Coherent forecast third-quarter revenue of $1.70–$1.84 billion and non-GAAP EPS of $1.28–$1.48.
9 February 2026
····
Lumentum stock jumps nearly 8% as AI capex wave lifts optics names into the weekend

Lumentum stock jumps nearly 8% as AI capex wave lifts optics names into the weekend

Lumentum Holdings shares surged 8% to $544.68 Friday after reporting fiscal Q2 revenue of $665.5 million and a backlog topping $400 million for optical circuit switches. The company expects Q3 revenue between $780 million and $830 million. Traders cited strong AI-driven demand but flagged risks if cloud customers pause orders. Lumentum will brief investors at the OFC conference on March 17.
6 February 2026
·······
Coherent stock jumps on AI optics demand bets as Wall Street lifts price targets

Coherent stock jumps on AI optics demand bets as Wall Street lifts price targets

Coherent shares rose 7.3% to $224.59 Friday after the company issued strong Q3 guidance and analysts raised price targets. Fiscal Q2 revenue reached $1.69 billion with adjusted EPS of $1.29. The company expects Q3 revenue between $1.70 billion and $1.84 billion, and EPS of $1.28 to $1.48. Demand from datacenter optics led growth, while industrial sales remained weaker.
6 February 2026
··
Coherent stock price: COHR whipsaws after earnings; AI data-center optics in focus

Coherent stock price: COHR whipsaws after earnings; AI data-center optics in focus

Coherent shares fell 0.8% to $209.24 in after-hours trading Thursday after a session marked by a 15% swing and heavy volume. The company reported fiscal Q2 revenue of $1.69 billion, above analyst expectations, and projected March-quarter revenue between $1.70 billion and $1.84 billion. Analysts raised price targets, but investor caution persists over margins and demand.
6 February 2026
···
Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent stock price whipsaws after earnings: COHR slides as outlook, trade risks come into focus

Coherent shares fell 3.9% to $202.69 in late morning New York trading Thursday after posting fiscal Q2 revenue of $1.69 billion, up 17% from last year. The company expects Q3 revenue between $1.70 billion and $1.84 billion, with non-GAAP EPS forecast at $1.28 to $1.48. Trading volume topped 5.8 million shares after a volatile open. Shares were briefly halted for volatility at 09:38 a.m. ET.
5 February 2026
··
Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent (COHR) stock jumps more than 6% — earnings and a Bystronic deal update are in focus

Coherent shares jumped over 6% Monday, trading as high as $229.10 after Bystronic confirmed it completed the purchase of Coherent’s Tools for Materials Processing business. The company will report fiscal second-quarter results after markets close Feb. 4. Analysts expect earnings of $1.22 per share on $1.6 billion in revenue. Intraday volatility spiked ahead of the results, with options pricing in a 15% move by Feb. 6.
2 February 2026
··
Why Coherent stock is jumping today as a unit sale closes and earnings loom

Why Coherent stock is jumping today as a unit sale closes and earnings loom

Coherent Corp shares rose 6.9% to $226.83 Monday ahead of its earnings report due Wednesday after market close. The move followed news that Bystronic finalized its purchase of Coherent’s Tools for Materials Processing unit. Morgan Stanley raised its price target to $190 but kept a neutral rating. Trading remained volatile as investors watched for updates on AI data center demand and debt repayment.
2 February 2026
·····
Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics (AAOI) stock jumps nearly 18% on Oxford Instruments Texas expansion deal

Applied Optoelectronics shares jumped nearly 18% to $44.05 midday after Oxford Instruments announced a plasma equipment supply deal for AOI’s Texas facility. The agreement supports AOI’s expansion in indium phosphide production for optical transceivers used in AI data centers. Investors also watched the Fed’s policy decision for its impact on tech stocks.
28 January 2026
······
Coherent (COHR) stock slid Friday — here’s what traders watch before Feb. 4 earnings

Coherent (COHR) stock slid Friday — here’s what traders watch before Feb. 4 earnings

Coherent shares fell 2.9% to $196.94 Friday, trading between $189.50 and $204.70. The company will report quarterly results after the market closes on Feb. 4, following the Federal Reserve’s January decision midweek. Stifel and Susquehanna raised their price targets for Coherent this week. Investors are watching for updates on networking orders and margins amid volatile tech valuations.
26 January 2026
··
Coherent stock: what to watch Tuesday after bondable diamond cooling launch

Coherent stock: what to watch Tuesday after bondable diamond cooling launch

Coherent shares fell 2.5% Friday to $191.04 ahead of the U.S. market holiday, after launching “bondable diamond” thermal-management components for chips. The stock saw heavy trading and volatility, opening at $197 and touching a low of $189.59. U.S. markets reopen Tuesday as Photonics West begins in San Francisco. Coherent forecasts Q2 fiscal 2026 revenue between $1.56 billion and $1.70 billion.
20 January 2026
·
Coherent stock price in focus as COHR heads for Tuesday restart after product flurry

Coherent stock price in focus as COHR heads for Tuesday restart after product flurry

Coherent shares fell 2.5% to $191.04 at Friday’s close after swinging between $189.59 and $201.93. The company launched a germanium-free electro-optic modulator and new imaging fiber assemblies, both set to debut at SPIE Photonics West Jan. 20–22. U.S. markets will be closed Monday for Martin Luther King Jr. Day. Coherent’s next earnings report is scheduled for Feb. 4.
19 January 2026
·
Coherent stock swings into Tuesday reopen as analysts cite AI-optics demand, Photonics West

Coherent stock swings into Tuesday reopen as analysts cite AI-optics demand, Photonics West

Coherent Corp shares fell 2.5% to $191.04 Friday after surging 6.4% Thursday. Analysts at Bank of America, Barclays, and Morgan Stanley raised price targets, citing strong optical transceiver demand tied to AI. Coherent launched new laser and imaging products this week and plans to debut its Sapphire XT platform at Photonics West in San Francisco. U.S. markets close Monday for Martin Luther King Jr. Day.
18 January 2026
··
Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent stock snaps back after steep slide as jobs data lifts tech — what COHR traders watch next

Coherent shares rose 2.8% to $178.06 Friday, rebounding after a 9.6% drop the previous day. The move followed a softer U.S. jobs report that shifted rate expectations and lifted tech stocks. Coherent’s next earnings report is expected in early February, with investors watching U.S. CPI data on Jan. 13. The stock’s price-to-earnings ratio stands at 227.5, well above the industry median.
10 January 2026
··
1 2 3

Stock Market Today

  • Wall Street Falls on Rising Oil Prices, Iran Concerns; Dow Drops 1.1%
    May 19, 2026, 6:07 AM EDT. Wall Street closed lower on May 18 as rising oil prices surged 3.4% to $109 a barrel and geopolitical tensions with Iran increased. The Dow Jones Industrial Average fell 1.1% to 49,526.17, led by a 4.4% drop in NVIDIA shares. The tech-heavy Nasdaq declined 1.5%, while the S&P 500 lost 1.2%. Defensive sectors like Energy rose as others, including Materials and Utilities, fell. The CBOE Volatility Index jumped 6.8%, signaling increased market fear. Industrial production surprised with a 0.7% April gain, and the NY Empire State Manufacturing Index surged to 19.6, pointing to robust manufacturing activity despite global tensions.

Latest articles

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

Virax Biolabs Shares Jumping Again Ahead of Nasdaq Open

19 May 2026
Virax Biolabs shares surged 53.1% Monday to $0.2350 and climbed another 17.1% in early Tuesday premarket trading, hitting $0.2751. The rally followed a paid RedChip TV appearance and a May 15 ownership filing showing Armistice Capital with a 4.99% stake. No new clinical or product updates were posted. Trading volume Monday reached about 765.2 million shares.
Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

Amesite Shares Rise Premarket After NurseMagic Signs Largest Client

19 May 2026
Amesite Inc. shares surged 218% to $2.50 in premarket trading after announcing its largest NurseMagic deployment with a 2,700-patient home-care client. The company disclosed $83,332 in quarterly revenue and a $678,061 net loss, with cash at $740,711 before a $2.2 million April financing. Amesite did not reveal the new contract’s value or customer name. Its latest filing cited “substantial doubt” about ongoing operations.
Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

Alphabet Approaches $5 Trillion With Google AI Cloud Move Targeting Nvidia

19 May 2026
Alphabet shares rose in pre-market trading Tuesday after Google and Blackstone announced a U.S. AI cloud venture, with Blackstone committing $5 billion to add 500 megawatts of data-center capacity by 2027. Alphabet’s Class A shares closed Monday at $396.94 and were quoted at $401.09 before the market opened. The move coincides with the first day of Google I/O and follows strong Q1 earnings.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop